Wu, S., Wang, J., Zhou, L., Su, D., Liu, Y., Liang, X., . . . Zeng, X. (2015). Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements. Thorac Cancer.
Chicago-stil citatWu, Shafei, Jinghui Wang, Lijuan Zhou, Dan Su, Yuanyuan Liu, Xiaolong Liang, Shucai Zhang, och Xuan Zeng. "Clinicopathological Characteristics and Outcomes of ROS1-rearranged Patients With Lung Adenocarcinoma Without EGFR, KRAS Mutations and ALK Rearrangements." Thorac Cancer 2015.
MLA-referensWu, Shafei, et al. "Clinicopathological Characteristics and Outcomes of ROS1-rearranged Patients With Lung Adenocarcinoma Without EGFR, KRAS Mutations and ALK Rearrangements." Thorac Cancer 2015.